Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody-associated disease: a systematic review and meta-analysis.

Lai, Qi-Lun; Zhang, Yin-Xi; Cai, Meng-Ting; Zheng, Yang; Qiao, Song; Fang, Gao-Li; Shen, Chun-Hong

Lai, Qi-Lun; Zhang, Yin-Xi; Cai, Meng-Ting; Zheng, Yang; Qiao, Song; Fang, Gao-Li; Shen, Chun-Hong.

Afiliação

Lai QL; Department of Neurology, Zhejiang Hospital, Hangzhou, China.
Zhang YX; Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Cai MT; Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zheng Y; Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Qiao S; Department of Neurology, Zhejiang Hospital, Hangzhou, China.
Fang GL; Department of Neurology, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, China.
Shen CH; Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou 310009, China.

Ther Adv Neurol Disord ; 14: 17562864211054157, 2021.

Article em En | MEDLINE | ID: mdl-34790259

Palavras-chave

immunosuppressive therapy; myelin oligodendrocyte glycoprotein antibodyassociated disease; relapses

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google